Bright Lights, Big City: PHI’s debut on the OTCQB in New York
We’re excited about our very own ‘big apple’ moment — PHI’s shares are now trading on the OTCQB Market! This marks a thrilling chapter in our mission to connect with more global investors and extend our impact in regenerative medicine. Our new presence on the OTCQB, under the ticker symbol OTCQB:PHIXF, complements our Stockholm listing and opens the door to new growth opportunities.
From Stockholm to New York
![](https://phiab.com/wp-content/uploads/2024/08/PHI-AB-now-also-listed-on-OTCQB-US-market-PHIXF-web.jpg)
PHI has received a warm welcome this week at the OTC Market Group’s headquarters in New York. A picture can’t fully capture our excitement and how this experience reinforces our commitment to our mission and our investors. This new venture into the US market is more than just a listing; it’s about making meaningful connections in this vibrant financial community and shaping our future to advance regenerative medicine with non-invasive live cell analysis (blog post).
Streaming now: CEO speaks on PHI’s exciting new chapter
Tune in: OTCQB podcast episode with PHI
Investor FAQ update to include your OTCQB questions
We’re updating our Investor FAQ to include your questions about this new chapter. Do you have any questions about our OTCQB dual-listing? Please send us your queries and help shape our FAQ update.
We’re thankful for the enthusiasm and support from our global community as we step into this new market. Let’s continue to shape the future of regenerative medicine together!